Dr. Emmanuel S. Antonarakis M.D.
Oncologist | Medical Oncology
1650 Orleans St Room 186 Baltimore MD, 21287About
Dr Antonarakis received his medical degree in 2003 from the University Of Wales College Of Medicine, Cardiff. He completed a residency in Internal Medicine at Johns Hopkins Bayview Medical Center in 2 ...
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Internal MedicineAmerican Board of Internal MedicineABIM- 2007
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals.
- Temperature modulation of DHPLC analysis for detection of coexisting constitutional and mosaic sequence variants in TSC2.
- Surgical correction of congenital lymphoedema of external female genitalia: case
- Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
- Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?
- Orientation of the stethoscope around the neck: a random phenomenon or an
- Images in clinical medicine. Acquired leukonychia totalis.
- Visual vignette. Necrobiosis lipoidica.
- Pemberton sign.
- Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review.
- A cut above.
- Rheumatoid arthritis masked by docetaxel chemotherapy in a patient with ovarian carcinoma.
- Does short-term ADT before and during radiation therapy improve outcomes in locally advanced prostate cancer?
- Is abiraterone acetate well tolerated and effective in the treatment of castration-resistant prostate cancer?
- Novel targeted therapeutics for metastatic castration-resistant prostate cancer.
Clinical Trials
- Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
- Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
- Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
- Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC
- Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy
Awards
- 2009 ASCO Young Investigator Award
Treatments
- Bladder Cancer, Kidney Cancer, Prostate Cancer And More
Professional Memberships
- Member American Society of Clinical Oncology (ASCO), American Medical Association (AMA)
Fellowships
- The Johns Hopkins Hospital/Oncology 2010
Dr. Emmanuel S. Antonarakis M.D.'s Practice location
Dr. Emmanuel S. Antonarakis M.D.'s reviews
Write ReviewPatient Experience with Dr. Antonarakis
Recommended Articles
- Breast Cancer Risk Could Depend on a Combination of Gene Variation and Environment
A recent topic for many people concerned about breast cancer is the genetic factors involved. Genetics is a confusing topic for many people because it can be hard to determine the exact risk of getting a disease. While we know that genetics is a factor, the specific genes that cause cancer have been...
- Bone Health Drugs for Breast Cancer
Like any other drug or therapy, breast cancer treatment also has its own side effects. One of the side effects of breast cancer treatment is rapid bone loss leading to osteoporosis. The following are treatments for breast cancer that can significantly cause bone loss:...
- Treatments for Bladder Cancer
The treatment options or medications for bladder cancer depend largely on the advancement of cancer. The treatment is different for the early stage non-invasive bladder cancer and the more advanced muscle-invasive bladder cancer.During treatment, all hospitals have multidisciplinary teams (MDTs),...
- Leptomeningeal Disease: When Breast Cancer Metastasize to the Brain
Introduction When breast cancer cells spread to the brain, it is called as brain metastases or secondary breast cancer. It is also known as metastatic breast cancer, advanced breast cancer, secondary or stage four breast cancer, or secondary tumor. When cancer cells reach the brain, it cannot be...
- What Specialist Conducts Chemotherapy?
Chemotherapy is a very delicate and complicated procedure. This is because it also has the ability to cause further complications in a person’s health while it is being used to treat another medical condition. Chemotherapy usually has side effects that can be very severe.Therefore it requires well...
- What Are Lymphocytes? Low, Normal, and High Lymphocyte Counts
Lymphocytes are a type of white blood cell produced in the bone marrow. A few lymphocytes enter the bloodstream while some move into the lymphatic system. Having a low or high lymphocyte count can help identify a person's medical condition. Normal lymphocyte counts usually vary from one laboratory...
Nearby Providers
- Dr. Michael Streiff M.D.1800 Orleans St Baltimore MD 21287
- Dr. Mark Levis M.D.1800 Orleans St Baltimore MD 21287
- Dr. Evan Jacob Lipson MD1650 Orleans St Baltimore MD 21287
- Dr. Douglas Gladstone M.D.1650 Orleans St Baltimore MD 21287
- Dr. Elias Zambidis M.D., PH.D.1800 Orleans St Baltimore MD 21287
- Dr. Elizabeth Jaffee M.D.1800 Orleans St Baltimore MD 21287